Identification of differentially expressed genes in a renal cell carcinoma tumor model after endostatin-treatment (Q40531862)

21 September 2017

Identification of differentially expressed genes in a renal cell carcinoma tumor model after endostatin-treatment (English)

1 reference

21 September 2017

7

Clemens Löwik

1 reference

21 September 2017

5

Ivo Que

1 reference

21 September 2017

Jens van Wijngaarden

1

1 reference

21 September 2017

Karien de Rooij

2

1 reference

21 September 2017

Ermond van Beek

3

1 reference

21 September 2017

Hans Bernsen

4

1 reference

21 September 2017

Victor W M van Hinsbergh

6

1 reference

21 September 2017

1 November 2004

1 reference

21 September 2017

Laboratory Investigation

1 reference

21 September 2017

84

1 reference

21 September 2017

11

1 reference

21 September 2017

1472-1483

1 reference

https://scigraph.springernature.com/pub.10.1038/labinvest.3700157

21 September 2017

0 references

cites work

Angiogenesis in cancer, vascular, rheumatoid and other disease

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700157

Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700157

Endostatin: an endogenous inhibitor of angiogenesis and tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700157

Cloning, expression, and in vitro activity of human endostatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700157

Endostatin inhibits VEGF-induced endothelial cell migration and tumor growth independently of zinc binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700157

Adenovirus-mediated gene transfer of endostatin in vivo results in high level of transgene expression and inhibition of tumor growth and metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700157

Systemic gene therapy with anti-angiogenic factors inhibits spontaneous breast tumor growth and metastasis in MMTVneu transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700157

Systemic inhibition of tumor growth and tumor metastases by intramuscular administration of the endostatin gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700157

Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700157

Phase I clinical trial of recombinant human endostatin administered as a short intravenous infusion repeated daily.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700157

Development of biologic markers of response and assessment of antiangiogenic activity in a clinical trial of human recombinant endostatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700157

Interaction of endostatin with integrins implicated in angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700157

Cell surface glypicans are low-affinity endostatin receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700157

Characterization of endostatin binding to heparin and heparan sulfate by surface plasmon resonance and molecular modeling: role of divalent cations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700157

Endostatin blocks vascular endothelial growth factor-mediated signaling via direct interaction with KDR/Flk-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700157

Endostatin is a potential inhibitor of Wnt signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700157

Endostatin binds to the catalytic domain of matrix metalloproteinase-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700157

A subtractive hybridisation method for the enrichment of moderately induced sequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700157

Mirror orientation selection (MOS): a method for eliminating false positive clones from libraries generated by suppression subtractive hybridization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700157

Tumour progression and angiogenesis in bone metastasis from breast cancer: new approaches to an old problem

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700157

Effect of angiogenic and antiangiogenic compounds on the outgrowth of capillary structures from fetal mouse bone explants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700157

A novel in situ hybridization signal amplification method based on the deposition of biotinylated tyramine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700157

Hypoxia in a human intracerebral glioma model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700157

Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700157

Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700157

Calpain activation is upstream of caspases in radiation-induced apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700157

Human tumstatin and human endostatin exhibit distinct antiangiogenic activities mediated by alpha v beta 3 and alpha 5 beta 1 integrins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700157

Endostatin's antiangiogenic signaling network

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700157

Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700157

Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700157

Mouse polymorphonuclear granulocyte binding to extracellular matrix molecules involves beta 1 integrins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700157

Endostatin Associates with Lipid Rafts and Induces Reorganization of the Actin Cytoskeleton via Down-regulation of RhoA Activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700157

Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700157

7 January 2021

Endostatin induces endothelial cell apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700157

7 January 2021

Phase I study of recombinant human endostatin in patients with advanced solid tumors

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700157

7 January 2021

Phase I pharmacokinetic and pharmacodynamic study of recombinant human endostatin in patients with advanced solid tumors

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700157

7 January 2021

Genomic organization, expression of the human CBFA1 gene, and evidence for an alternative splicing event affecting protein function

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700157

7 January 2021

Calpain activation in apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700157

7 January 2021

Ceramide selectively decreases tau levels in differentiated PC12 cells through modulation of calpain I

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700157

7 January 2021

Reovirus-induced apoptosis is preceded by increased cellular calpain activity and is blocked by calpain inhibitors

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700157

7 January 2021

Bax cleavage is mediated by calpain during drug-induced apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700157

7 January 2021

Caspase-dependent activation of calpain during drug-induced apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700157

7 January 2021

The angiogenesis inhibitor endostatin impairs blood vessel maturation during wound healing.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700157

7 January 2021

Excessive extramedullary hematopoiesis in Cbfa1-deficient mice with a congenital lack of bone marrow

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700157

7 January 2021

Neutrophils as a key cellular target for angiostatin: implications for regulation of angiogenesis and inflammation.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700157

7 January 2021

10.1038/LABINVEST.3700157

Identifiers

DOI

1 reference

Dimensions Publication ID

21 September 2017

0 references

1 reference